Cancer Incidence, Healthcare Access, and Support Resource Distribution in Delaware : A Statewide Epidemiological Analysis, 2018-2022.
- 1Intern, Delaware Academy of Medicine and Public Health; Graduate Student, New York University.
- 2Executive Director, Delaware Academy of Medicine and Public Health.
Abstract
Delaware has historically experienced cancer incidence rates exceeding the national average, making an assessment of cancer burden, healthcare access, and support resource availability essential for informing public health policy and intervention. This paper analyzes cancer in Delaware from 2018 to 2022, examining patterns by cancer type, demographics, and geography, while also evaluating whether the distribution of oncology specialists and support resources align with the areas of greatest need among the population. The majority of the data about Delaware was sourced from the Delaware Department of Health and Social Services Division of Public Health's report on Small Area-Level Cancer Incidence in Delaware 2018-2022. This information was then supplemented with additional research and data surrounding provider location, state screening program information, and cancer support organization resources. Between 2018 and 2022, Delaware recorded 32,090 newly diagnosed cancer cases with an age-adjusted all-site incidence rate of 469.9 per 100,000 people, which is greater than the national average of 448.6 per 100,000. Geographic analysis revealed variation across the state's three counties and 15 cancer reporting zones. In this data, Kent County had the highest county-level incidence rate despite having the fewest cancer specialists. Sussex County however faced the most disparity in terms of access, having a cases-per-medical-oncologist ratio almost five times that of New Castle County. Both cancer support resources and screening programs had a majority concentration in New Castle County. The findings of this analysis highlight geographic and demographic disparities in cancer burden across the state of Delaware, and stress the importance of targeted interventions to improve the health outcomes of Delaware residents no matter where they live.
Related
- One‐Year Healthcare Utilization and Costs After Emergency Department Encounters for Uncomplicated Appendicitis: A Statewide Observational Study
- A retrospective epidemiological study of screening-derived solid cancer incidence proxy rates in South Korea before and after COVID-19 using Korean National Health Insurance Service data
- Epidemiological trend comparison and incidence prediction for elderly lung cancer in 204 countries and territories: a retrospective study.
- Epidemiological Characteristics and Incidence Trends of Hemorrhagic Fever With Renal Syndrome in Shandong Province, China: Retrospective Observational Study With Forecasting
- Global burden of dengue on healthcare systems: a meta-analysis of healthcare resource utilisation
BibTeX
@article{stephens2026cancer,
title = {{Cancer Incidence, Healthcare Access, and Support Resource Distribution in Delaware : A Statewide Epidemiological Analysis, 2018-2022.}},
author = {Ryan Stephens and Katherine Smith},
journal = {Delaware journal of public health},
year = {2026},
month = oct,
doi = {10.32481/djph.2026.10.18},
url = {https://europepmc.org/article/MED/42948468},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Cancer Incidence, Healthcare Access, and Support Resource Distribution in Delaware : A Statewide Epidemiological Analysis, 2018-2022.
AU - Ryan Stephens
AU - Katherine Smith
PY - 2026
DA - 2026/10/26
JO - Delaware journal of public health
DO - 10.32481/djph.2026.10.18
UR - https://europepmc.org/article/MED/42948468
AB - Delaware has historically experienced cancer incidence rates exceeding the national average, making an assessment of cancer burden, healthcare access, and support resource availability essential for informing public health policy and intervention. This paper analyzes cancer in Delaware from 2018 to 2022, examining patterns by cancer type, demographics, and geography, while also evaluating whether the distribution of oncology specialists and support resources align with the areas of greatest need among the population. The majority of the data about Delaware was sourced from the Delaware Department of Health and Social Services Division of Public Health's report on Small Area-Level Cancer Incidence in Delaware 2018-2022. This information was then supplemented with additional research and data surrounding provider location, state screening program information, and cancer support organization resources. Between 2018 and 2022, Delaware recorded 32,090 newly diagnosed cancer cases with an age-adjusted all-site incidence rate of 469.9 per 100,000 people, which is greater than the national average of 448.6 per 100,000. Geographic analysis revealed variation across the state's three counties and 15 cancer reporting zones. In this data, Kent County had the highest county-level incidence rate despite having the fewest cancer specialists. Sussex County however faced the most disparity in terms of access, having a cases-per-medical-oncologist ratio almost five times that of New Castle County. Both cancer support resources and screening programs had a majority concentration in New Castle County. The findings of this analysis highlight geographic and demographic disparities in cancer burden across the state of Delaware, and stress the importance of targeted interventions to improve the health outcomes of Delaware residents no matter where they live.
SN - 2639-6378
ER -